Tiny Cancer-Targeting bubbles tested in bladder patients
NCT ID NCT06173349
Summary
This early-stage trial is testing a new targeted treatment for bladder cancer that has returned or hasn't responded to standard therapy. Researchers are using microscopic particles designed to deliver cancer-killing medication directly to tumor cells in the bladder. The study will enroll 12 patients to first determine if this approach is safe and well-tolerated before testing effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE 0A BLADDER CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis Comprehensive Cancer Center
RECRUITINGSacramento, California, 95817, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.